More volume. Less quality.
One metric grows while the commercial outcome deteriorates.
Marketing Analytics
When one metric improves and another gets worse, I analyze what changed, what the evidence shows and what is still a hypothesis. I organize it into a diagnosis, prioritized hypotheses and a plan to validate them before deciding.
I apply it to questions about investment, performance, audiences, messaging and measurement, using SQL on GA4, ad-platform and CRM data.
01 / When data does not give one clear answer
One metric can improve while another gets worse. Deciding requires separating what is known, what is still assumed and what needs checking.
One metric grows while the commercial outcome deteriorates.
Platforms, CRM data or periods can tell different stories.
Audience, messaging, measurement or context could explain the change.
My starting point: separate evidence, hypotheses and questions that remain open.
02 / What the analysis produces
How I structure the work: a clearly framed decision, comparable evidence and a concrete way to reduce uncertainty.
The pending decision, the alternatives and the result that could change the action.
KPIs with definitions, formulas, sources, populations, observation windows and limitations.
What changed, by how much, where it is concentrated and what the data can establish.
Possible explanations ranked by evidence, relevance and feasibility of validation.
What evidence to gather next, how to obtain it and which decision criteria to use.
Experiment design, when appropriate.Paid Social · May → June 2026
The selected piece highlights the parts of the brief it feeds.
03 / Interactive diagnosis
The same campaign can tell different stories depending on the metric you observe. Change the lens and see how the decision evolves.
Interactive demo · simulated dataPaid Social · May → June 2026
Unchanged spend
Spend per period: US$10,000 · same channel
Observe one metric, then add more evidence before deciding.
Qualified within seven days of each enquiry. Descriptive comparison: it does not identify a cause or demonstrate a realized improvement.
Question: Start with a lens.Clarifying qualification requirements may improve the proportion of visitors who generate a qualified lead.
Proposed test design. A favorable result is not assumed. Acquisition and follow-up are planned separately; seven days of follow-up do not mean a seven-day test.
04 / How I approach it
One decision. Five steps.
I start from what needs deciding and which outcome actually matters.
I document the pending action, alternatives, decision owner and constraints. A broad question becomes a comparison the data can answer.
I define KPIs, sources, populations and windows so the comparison is valid.
Formulas, exclusions, identifiers and cohort maturity are documented before comparing.
I define with the sales team what qualifies an enquiry, where that decision is recorded and which identifier prevents duplicates. I document the source, formula, time zone and exclusions so two people can reproduce the same KPI.
In this example, each enquiry has seven days to qualify. I compare cohorts that have completed that follow-up; recent records remain pending, so incomplete observation is not mistaken for lower quality.
Review criterionSpend must cover the same scope. With no qualified contacts, cost per qualified contact is undefined and is never reported as zero.
cohort = unique enquiries from the period
qualified = meet criteria within 7 days
mature = latest enquiry + 7 days ≤ cutoff
rate = qualified / enquiries
cost = spend / qualified
denominator = 0 → undefinedIllustrative window. Commercial criteria and follow-up are agreed with the team.
I locate what changed, by how much and where the variation is concentrated.
Every figure retains its denominator and source; breakdowns are used only where coverage and follow-up are comparable.
Enquiries rise from 300 to 400, while qualified contacts fall from 90 to 40. I show the rate, its percentage-point change and cost per outcome, retaining the denominators needed to check each figure.
I review changes in coverage, qualification criteria and channel mix. Breakdowns are used only where the data support a valid comparison. A change over time suggests hypotheses but does not establish that a campaign caused it.
Review criterionI check definitions, currency, complete follow-up and comparable coverage. Unreconciled differences are documented before recommending an intervention.
Period A: 90 / 300 = 30%
Period B: 40 / 400 = 10%
Change: 10% − 30% = −20 pp
Cost A: 10,000 / 90 ≈ US$111.11
Cost B: 10,000 / 40 = US$250
Readout: observed decline; cause unresolvedSynthetic data. These totals describe the change without establishing its cause.
I separate findings from hypotheses and prioritize those worth investigating.
I rank hypotheses by evidence, potential impact and feasibility. For each, I record what observation would support it, what could refute it and which alternative remains open.
I define what to observe, measure or test to reduce uncertainty.
Experiment design, when appropriate.With enough sample and traceability, I design an experiment; otherwise, I use another validation path and state its limitations.
I propose stable assignment and one binary outcome per visitor: at least one qualified lead. Intent-to-treat analysis includes everyone assigned, including visitors who never submit the form. The offer and qualification rules remain consistent.
I plan the minimum detectable effect, power, sample and duration before starting. The final assessment includes the difference and confidence interval, form errors and cost. A favorable interim result does not trigger an early finish.
Review criterionI check assignment imbalances and missing data before interpreting results. Without traceability or sufficient sample, the hypothesis remains unresolved.
A = current message · B = explicit requirements
unit = visitor with persistent assignment
outcome = ≥1 qualified lead per visitor
denominator = everyone assigned to the variant
plan = minimum effect + power → sample
readout = difference + interval + guardrails
close = planned sample and durationAcquisition and follow-up windows are specified separately: seven days to qualify a lead does not mean a seven-day experiment.
05 / Method limits
The method focuses on one concrete question and the evidence available to answer it. What it cannot establish is written down.
06 / Technical questions
Not on its own. A dashboard shows changes; diagnosis explains what changed, against which denominator and what remains to validate. A dashboard is one input to a diagnosis, not the diagnosis itself.
Not always. Comparisons identify changes and associations; establishing a cause requires an appropriate design. I distinguish observed evidence, hypotheses and outstanding validation.
First I estimate the difference that matters and the sample required. Improving measurement, gathering further evidence or exploratory research may be more useful, with explicit limits.
No. I experiment when it is feasible and addresses the decision. Validation can also mean reconciling sources, reviewing cohorts or investigating changes.
I set the expected evidence, metric, comparison and criteria before looking at the data. The data can support, contradict or leave a hypothesis unresolved; a temporary improvement alone does not establish a winner.
They add context when they help answer the question. Social listening, search trends and audience signals have their own coverage and biases; I document them and do not treat them as representative of the whole audience.
Because a recent cohort has not had time to qualify yet. I compare mature cohorts with the same window; otherwise the latest period looks worse simply because it is newer.
Calculations, joins and consistency checks can be automated and re-run. Framing the decision, ranking hypotheses and judging when the evidence is enough remain human calls, documented so others can review them.
Contact
If you work in marketing measurement and want to compare approaches, message me. The data and examples on this page are synthetic; the method is the one I apply.
Message me on LinkedInExplore the Labs